chr13-51944145-G-T
Variant summary
The NM_000053.4(ATP7B):c.3207C>A (p.His1069Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a cumulative frequency of 0.000944 (AC=1,523) in the gnomAD database across 1,614,166 control chromosomes, including 1 homozygote. The grpmax filtering allele frequency (95% CI) is 0.00143. In-silico predictor (REVEL) classifies this variant as likely damaging/oncogenic. Splicing prediction tools (SpliceAI) predict no significant impact on normal splicing. Variant has been reported in ClinVar as Pathogenic/Likely Pathogenic (★★). ClinVar reports functional evidence for this variant: "SCV000052016: The most pronounced variant effect results in <10% of normal nucleotide binding activity (e.g., Morgan_2004). PMID:17717039, 10544227, 11690702, 15205462, 24897373, 21334398" and additional evidence is available in ClinVar. A different missense at the same amino acid position has been reported as Pathogenic/Likely Pathogenic in ClinVar: p.H1069L: Likely_pathogenic (ClinVar VariationId 2120118, 1 star) Other variants at the same amino acid position have been reported in ClinVar (not pathogenic): p.H1069= (synonymous): Likely_benign (ClinVar VariationId 2746502, 1 star) This exact variant is curated in the UniProt human variants database as Uncertain Significance.
Frequency
Consequence
NM_000053.4 missense
Scores
Clinical Significance
Conservation
Publications
- Wilson diseaseInheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Genomics England PanelApp, ClinGen, Orphanet, Natera, Labcorp Genetics (formerly Invitae)
Genome browser will be placed here
Classification according to ACMG Germline Pathogenicity v2019
Our verdict: Pathogenic. The variant received 13 points.
| Apply | Criterion Code & Title / Strength | Rationale / Clinical Context | |
|---|---|---|---|
| PS3Functional studies show damaging effect | Well-established functional study supports damaging effect (PS3); SCV000052016: The most pronounced variant effect results in <10% of normal nucleotide binding activity (e.g., Morgan_2004). PMID: 17717039, 10544227, 11690702, 15205462, 24897373, 21334398; SCV000602583: Functional studies indicate that the variant protein has altered subcellular localization (Payne 1998, van den Berghe 2009), reduced affinity to ATP (Morgan 2004, Rodriguez-Granillo 2008) and reduced half-life (Payne 1998). Cells expressing the variant protein show reduced viability when exposed to increased levels of copper (Payne 1998). PMID: 9724794; SCV000626851: Experimental studies have shown that this missense change affects ATP7B function (PMID: 9724794, 19937698, 22240481, 24909901).; SCV000967653: "In vitro functional studies provide some evidence that the p.His1069Gln variant may result in reduced ATP7B protein expression (van den Berghe 2009)"; SCV001142439: Functional studies demonstrate that p.His1069Gln had a very low activity compared to wildtype (PMID: 22240481), resulted in reduced ATP7B protein expression (PMID: 19937698), and caused subcellular mislocalization (PMID: 24909901).; SCV002051776: Functional studies demonstrate that this substitution results in mislocalization and increased degradation of the ATP7B protein in cells.; SCV002767518: Functional studies of mutant protein disrupts intracellar copper balance and reduced protein stability (Huster D. et al. (2003), Rodriguez-Granillo, A., et al. (2008)).; SCV003920292: In vivo and In vitro functional studies suggest that this variant reduces ATP binding and is retained in the endoplasmic reticulum (Morgan 2004 PMID:15205462, Mercer 2017 PMID:28119449, Parisi 2018 PMID:29674751).; SCV004361971: Functional studies have shown that this variant results in reduced ATP7B protein expression, subcellular mislocalization of the ATP7B protein to the endoplasmic reticulum where it undergoes rapid degradation, and partial loss of copper export activity (PMID: 8298641, 9654149, 9724794, 10051024, 12557139, 17717039, 18692069, 19937698, 21398519, 22240481, 22692182, 24253677, 24909901, 28119449, 29674751, 30026388).; SCV004845404: Functional studies have shown that this variant results in reduced ATP7B protein expression, subcellular mislocalization of the ATP7B protein to the endoplasmic reticulum where it undergoes rapid degradation, and partial loss of copper export activity (PMID: 8298641, 9654149, 9724794, 10051024, 12557139, 17717039, 18692069, 19937698, 21398519, 22240481, 22692182, 24253677, 24909901, 28119449, 29674751, 30026388).; SCV000329091: Published functional studies show the H1069Q variant has significantly reduced ATP binding affinity and reduced protein stability, leading to impaired copper transport (Dmitriev et al., 2011; Morgan et al., 2004; Rodriguez-Granillo et al., 2008; Chesi et al., 2016);; SCV001247795: PS3:Moderate; SCV004026153: PS3; SCV002610410: Based on several functional studies, this mutation affects ATP binding, protein dynamics, and chemical and thermal stabilities relative to wild type (Rodriguez-Granillo, 2008; Dmitriev, 2011; Morgan, 2004). | ||
| PM2Absent/extremely low in population databases | Rare in gnomAD for AR/unknown gene (popmax AF below threshold) — PM2 Supporting; GnomAD popmax AF = 0.00143 — borderline rare for AR gene (base 0.001, raised to 0.00322 by highest known P/LP ClinVar AF 0.00322) — PM2 supporting. | ||
| PM5Novel missense at known pathogenic residue | Different pathogenic missense at same AA residue in ClinVar (PM5); ClinVar contains a germline Pathogenic/Likely Pathogenic entry at the same amino acid position with a different amino acid change: p.H1069L: Likely_pathogenic (ClinVar VariationId 2120118, 1 star); Other variants at the same amino acid residue (not pathogenic): p.H1069= (synonymous): Likely_benign (ClinVar VariationId 2746502, 1 star) | ||
| PP3Computational evidence supports damaging effect | Germline meta computational scorer (REVEL/MetaRNN/BayesDel) predicts damaging effect — moderate evidence (PP3); Splicing verdict: not pathogenic.; Germline computational verdict: pathogenic (Moderate). | ||
| PP5Reputable source reports pathogenic | ClinVar 2-star pathogenic — strong (PP5); ClinVar submissions overwhelmingly pathogenic (≥10 total, ≥80% P/LP, <10% B/LB) — strong (PP5, count-based); ClinVar germline classification: Pathogenic/Likely Pathogenic, 2 star(s). ClinVar submissions strongly and reliably favor pathogenicity (43/43 total P/LP). |
Variant Effect in Transcripts
Automated classification analysis was done for transcript: NM_000053.4. You can select a different transcript below to see updated classification assignments.
RefSeq Transcripts
| Sel. | Gene / Transcript | Tags | HGVSc / HGVSp | Effect | Exon rank | Protein / UniProt |
|---|---|---|---|---|---|---|
ATP7B | MANE Select | c.3207C>A p.His1069Gln | missense | Exon 14 of 21 | Prot: NP_000044.2 UniProt: | |
ATP7B | c.3207C>A p.His1069Gln | missense | Exon 15 of 22 | Prot: NP_001393440.1 UniProt: | ||
ATP7B | c.3207C>A p.His1069Gln | missense | Exon 15 of 22 | Prot: NP_001393441.1 UniProt: |
Ensembl Transcripts
| Sel. | Gene / Transcript | Tags | HGVSc / HGVSp | Effect | Exon rank | Protein / UniProt |
|---|---|---|---|---|---|---|
ATP7B | TSL:1MANE Select | c.3207C>A p.His1069Gln | missense | Exon 14 of 21 | Prot: ENSP00000242839.5 UniProt: | |
ATP7B | TSL:1 | c.3063C>A p.His1021Gln | missense | Exon 14 of 21 | Prot: ENSP00000489398.1 UniProt: | |
ATP7B | TSL:1 | c.3012C>A p.His1004Gln | missense | Exon 13 of 20 | Prot: ENSP00000393343.2 UniProt: |
Frequencies
Allele frequencies (AF), counts (AC/AN), homozygotes and coverage
| Source / population | AF | AC | Hom | AN | Coverage |
|---|---|---|---|---|---|
Global population databases 6 sources | |||||
GnomAD3 genomes | AF: 0.000933 | AC:142 | Hom:0 | AN:152184 | Cov:32 |
GnomAD2 exomes | AF: 0.000922 | AC:230 | AN:249392 | ||
GnomAD4 exome | AF: 0.000945 | AC:1381 | Hom:1 | AN:1461864 | Cov:31 |
GnomAD4 genome | AF: 0.000932 | AC:142 | Hom:0 | AN:152302 | Cov:32 |
TOPMed (Bravo) | AF: 0.000910 | AC:241 | Hom:0 | AN:264690 | |
ALFA (dbGaP/dbSNP Allele Frequency Aggregator) | AF: 0.00126 | AC:671 | Hom:0 | AN:534646 | |
Local & regional cohorts 3 sources | |||||
Denmark Genome | AF: 0.00333 | AC:1 | AN:300 | ||
ESP6500 (Exome Variant Server) | AF: 0.000882 | AC:11 | AN:12478 | ||
Turkish Variome | AF: 0.000299 | AC:2 | Hom:0 | AN:6682 | |
Case/control cohorts
| Cohort | Cases | Controls | ||||
|---|---|---|---|---|---|---|
| AF | AC | AN | AF | AC | AN | |
ASC | 0.00126 * | 14 | 11112 | 0.000908 * | 16 | 17618 |
BipEx | 0.000844 | 24 | 28420 | 0.00128 | 37 | 28844 |
Epi25 | 0.00105 | 44 | 41958 | 0.00120 | 80 | 66886 |
SCHEMA | 0.000542 | 66 | 121786 | 0.000819 | 156 | 190524 |
ClinVar
Computational Scores
| Algorithm | Calibrated pred. | Score | Prediction |
|---|---|---|---|
AlphaGenome AVI | Pathogenic | 26 | |
AlphaMissense | Pathogenic | 0.99 | |
BayesDel_addAF | Pathogenic | 0.22 | D |
BayesDel_noAF | Pathogenic | 0.54 | |
CADD | Benign | 23 | |
DANN | Benign | 0.97 | |
DEOGEN2 | Pathogenic | 0.97 | D |
Eigen | Uncertain | 0.37 | |
Eigen_PC | Uncertain | 0.28 | |
FATHMM_MKL | Uncertain | 0.92 | D |
FuncVEP CTI | Pathogenic | 0.99 | |
GPN-Star LLR | N/A | -8.4 | |
GPN-Star score | N/A | 8.4 | |
LIST_S2 | Uncertain | 0.97 | D |
M_CAP | Pathogenic | 0.91 | D |
MetaRNN | Pathogenic | 0.95 | D |
MetaSVM | Pathogenic | 0.93 | D |
Mutation Taster | N/A | 0/100 | disease causing (ClinVar) |
MutationAssessor | Pathogenic | 3.9 | H |
PhyloP100 | Benign | 2.7 | |
popEVE | Benign | -3.7 | |
PrimateAI | Uncertain | 0.68 | T |
PROVEAN | Pathogenic | -7.5 | D |
REVEL | Pathogenic | 0.91 | |
Sift | Pathogenic | 0.0 | D |
Sift4G | Pathogenic | 0.0010 | D |
Varity_R | N/A | 0.95 | |
VESM-3B | Benign | -13 |
Splicing Scores
| Algorithm | Calibrated pred. | Score | Prediction |
|---|---|---|---|
Pangolin (max) | Benign | 0.0 | |
SpliceAI score (max) | Benign | 0.0 | Details are displayed if max score is > 0.2 |
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.